SOTAC — Sotac Pharmaceuticals Balance Sheet
0.000.00%
- IN₹1.38bn
- IN₹1.69bn
- IN₹1.04bn
- 12
- 27
- 51
- 17
Annual balance sheet for Sotac Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.86 | 4.37 | 0.276 | 96 | 34.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 73.5 | 60.5 | 149 | 115 | 265 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 137 | 173 | 259 | 366 | 606 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 160 | 166 | 87.9 | 141 | 336 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 304 | 347 | 353 | 548 | 1,053 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 193 | 228 | 276 | 271 | 437 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 273 | 322 | 286 | 433 | 601 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 30.6 | 24.9 | 66.2 | 115 | 453 |
Total Liabilities & Shareholders' Equity | 304 | 347 | 353 | 548 | 1,053 |
Total Common Shares Outstanding |